SS1/20 – Solvency II: Prudent Person Principle

1.1

This Supervisory Statement (SS) sets out the PRA’s expectations of firms in accordance with the requirements under the Prudent Person Principle (PPP) under the Solvency II Directive regarding:

1. (a) their development and maintenance of an investment strategy;
2. (b) their management of risks arising from investments and their internal governance within the investment function; and
3. (c) their investment in assets not admitted to trading on a regulated market (hereafter ‘non-traded assets’)^[1] and intragroup loans and participations.

1.2

This SS is addressed to all UK Solvency II firms, including in the context of provisions relating to Solvency II groups, mutuals, third-country branches, the Society of Lloyd’s and its managing agents (collectively called ‘firms’ in this SS). 

1.3

The PRA notes that the PPP sets objective standards for prudent investment.^[2] These include standards in relation to portfolio diversification,^[3] the use of financial derivatives,^[4] exposure to non-regulated markets^[5] and risk concentration,^[6] asset-liability matching,^[7] and the security, quality and profitability of the whole investment portfolio.^[8] Compliance with these standards must be assessed on an objective basis, from the standpoint of the hypothetical prudent person in similar circumstances (taking into account all relevant factors case-by-case), rather than a firm’s subjective view about the prudence of its investment standards. This does not mean that a firm’s own views about the prudence of its investments are irrelevant or would be disregarded. Indeed, firms are required to make their own judgments about the prudence of the way they manage their business for the purposes of the risk management requirements in Solvency II. Nor does this imply that the same investment policy or the same investment limits ought to apply to different firms with different business strategies and risk profiles.

1.4

Compliance with the PPP must be considered on a case-by-case basis, as what is prudent for one firm, based on its particular business strategy and risk profile, may not be prudent for a different firm. When applied to a particular firm’s circumstances, the PPP’s standards are likely to allow for a range of reasonable investment strategies. In line with the PRA’s supervisory approach to insurance regulation, the PRA will exercise its independent judgement, and where it concludes that a firm is not meeting the PPP’s standards it will expect the firm’s senior managers responsible for investment to take action.

1.5

The SS should be read in conjunction with the following:

• The Investments, Conditions Governing Business and Valuation Parts of the PRA Rulebook;
• Chapters I (General Provisions), II (Valuation of assets and liabilities), VI (Solvency capital requirement - full and partial internal models), IX (System of Governance), XII (Public disclosure) and XIII (Regular supervisory reporting) and Article 376 (significant risk concentrations) of the Commission Delegated Regulation (EU) 2015/35;
• ‘The PRA’s approach to insurance supervision’;^[9]
• SS5/19 ‘Liquidity risk management for insurers’;^[10]
• SS41/15 ‘Solvency II: applying EIOPA Set 2, System of Governance and ORSA Guidelines’;¹¹
• SS4/18 ‘Financial management and planning by insurers’;^[12]
• SS19/16 ‘Solvency II: ORSA’;^[13]
• SS3/17 ‘Solvency II: illiquid unrated assets’;^[14]
• SS7/18 ‘Solvency II: Matching adjustment’;^[15]
• SS5/16 ‘Corporate governance: Board responsibilities’;^[16]
• SS3/19 ‘Enhancing banks’ and insurers’ approaches to managing the financial risks from climate change’;^[17]
• SS10/18 ‘Securitisation: General requirements and capital framework’;^[18]
• SS35/15 ‘Strengthening individual accountability in insurance’;^[19]
• Policy Statement 15/18 ‘Strengthening individual accountability in insurance: Extension of the SM&CR to insurers’;^[20]
• SS1/19 ‘Non-binding PRA materials: The PRA’s approach after the UK’s withdrawal from the EU’;^[21]
• SS20/16: ‘Solvency II: reinsurance – counterparty credit risk’;^[22] and
• EIOPA Guidelines on the systems of governance.^[23]

1.6

In accordance with Solvency II,^[24] the PRA rules require that ‘as regards investment risk, a firm must demonstrate that it complies with the Investments Part of the PRA Rulebook’.^[25] Accordingly, this SS addresses firms’ investment risk management practices and sets out some specific areas where the PRA would expect firms to pay particular attention in order to comply with the PPP. 

1.7

The PRA also reminds firms:

• that in accordance with Solvency II, the PRA must review and evaluate firms’ compliance with matters including the PRA’s Investment Rules, which implement the Solvency II PPP;^[26]
• of the responsibilities resting with Senior Management Functions under the Senior Managers and Certification Regime. Specifically, the Chief Risk Officer is responsible for managing and reporting to the board on the risk management strategies and processes in place, including those relating to investments;
• that if firms appear to the PRA to be in breach of the PRA Investment Rules, the PRA would consider exercising its relevant supervisory powers under section 55M of the Financial Services and Markets Act 2000; and
• that a breach of the PPP may be associated with a failure to meet the requirements set out in the Conditions Governing Business Part of the PRA Rulebook. The PRA may consider imposing capital add-ons when certain of these requirements are breached.

1.8

The expectations set out in this SS do not amend the scope of the requirements that apply under Solvency II rules in the PRA Rulebook and under directly applicable EU regulations. In some cases, the rules or regulations apply at a portfolio level while in others the requirements are more granular.^[27] Accordingly, the level of granularity at which the expectations in this SS should be applied will depend in each case on (among other things) the scope of all relevant requirements to which the expectation refers or relates and the specific circumstances of each firm case-by-case, taking into account the principle of proportionality.

2.1

The PRA expects firms to develop and document an investment strategy which describes at least:

• investment objectives and strategic asset allocation;
• consideration of investment constraints when setting investment objectives and strategic asset allocation;
• alignment of the investment strategy with the business model and, where appropriate, how the strategy takes into account the nature and duration of a firm’s liabilities and obligations, and the best interests of policyholders;
• alignment of investment strategy with board risk appetite, risk tolerance limits and investment risk and return objectives; and
• a complete list of assets and how those assets have been invested in accordance with the PPP (in line with the requirements set out in Article 309(2)(e) of the Delegated Regulation).

2.2

Firms should review their investment strategy on an annual basis and additionally, where appropriate, following a major external event or material change in the firm’s risk profile.

2.3

The continuing appropriateness of, or significant changes to, the investment strategy should be challenged, approved and controlled by the board or relevant sub-committee of the board. These changes might include, but are not limited to, situations where the firm is planning to invest in a new asset class, make a material, non-routine investment or materially alter the composition of its investment portfolio. Firms wishing to invest in asset classes not already approved by their board should conduct a comprehensive risk assessment to ensure all the necessary expertise, systems and processes are in place to value the asset, and to identify, measure, manage, monitor, control and report associated risks.

2.4

A firm must demonstrate that it complies with the Investments Part of the PRA Rulebook.^[28] While the PRA is not seeking to impose additional reporting requirements, it considers that a firm’s board cannot make effective decisions if it receives information piecemeal. Accordingly, the PRA expects that firms document compliance in a way that enables the board to effectively engage with, understand and challenge the material. Firms should be able to provide evidence of this compliance to the PRA on request.

3.1

The PRA expects investments to be aligned with the firm's risk appetite, risk management policies, risk tolerance limits and investment strategy alongside the firm’s overall business model (including the profile of their products and policyholders).

3.2

Firms may only invest in assets the risks of which they are able to identify, measure, monitor, manage, control, report and take into account in their assessment of own solvency needs in the own risk and solvency assessment (ORSA).^[29] Firms’ risk management frameworks should deliver this. Chapter 4 sets out the PRA’s expectations for investment risk management where firms have outsourced their investment activities.

3.3

Paragraphs 3.4 to 3.23 of this chapter do not apply to firms investing in assets covering technical provisions for linked long-term contracts of insurance, except where the assets are held to cover the additional technical provisions in respect of policyholder liabilities, including those for any guarantee of investment performance or other guaranteed benefit provided under those contracts.

3.4

The PRA expects that when firms invest in asset structures or other investments where the risk exposure is dependent on the performance of underlying assets (including securitisations, open-ended investment companies and derivatives), they should also include the risks of these underlying assets within the scope of their investment risk management framework.

3.5

As part of measuring their risks, the PRA expects firms to quantify, under a range of scenarios, the potential impact of investment risks crystallising on their solvency position and their ability to pay policyholders, before and after management actions. Firms are expected to identify scenarios that would cause these risks to crystallise, and to identify and analyse potential risk management actions, in response to stress scenarios.

3.6

Firms’ investment risk monitoring should cover, but not be limited to:

• changes in the value and volatility of their investment portfolios and individual assets and the firm’s ongoing ability to monitor these;
• changes in the characteristics of the assets held (eg changes in the credit quality);
• changes in the value or characteristics of underlying exposures on which the performance of the asset(s) invested in depend;
• changes in the external environment which may affect the security of assets;
• breaches of internal quantitative limits for assets and exposures (see paragraph 3.10 of this SS);
• concentrations of single risks in the investment portfolio (eg counterparty, asset class, geographical industry or sector); and
• changes to the firm’s risk profile which may lead to asset-liability mismatch.

3.7

The board and any relevant sub-committees of the board should receive appropriate, accurate and timely management information on the firm’s investment risks. This management information should be provided, at a minimum, whenever the board or relevant committee meets to review the investment strategy, internal investment limits or investment risks. Firms are reminded of the requirement to at least ensure that their investment risk management feeds in to their ORSA process and report,^[30] and the PRA expects firms to pay particular attention to this where investment risk is assessed to be a key risk currently facing the firm or likely to face the firm in the future.

3.8

The PRA reminds firms of the requirements of Investments 5.2(1). Where firms have hedged risks with derivatives and similar commitments, the PRA expects firms to be able to monitor the effectiveness of any hedge in mitigating the relevant risk exposure, and take remedial action in the event that it becomes less effective. The PRA notes that the requirements of Investments 5.2(1) apply to derivatives and quasi-derivatives, and as such, firms may only invest in such instruments where it contributes to a reduction of risks or facilitates efficient portfolio management.^[31]

3.9

The PRA expects firms to pay particular attention to the measurement and control of credit spread and default risk (including credit transition downgrade/upgrade risk). In particular, the PRA expects firms that outsource credit risk assessments to have sufficient in-house expertise to appropriately monitor the risks associated with this practice, and reminds firms of their obligations under Article 259(4) of the Delegated Regulation. Where firms internally assign credit ratings for unrated assets, firms are reminded of the PRA’s expectations as set out in SS3/17.

3.10

The risk management system in accordance with Solvency II must cover areas, including those listed below, and firms must produce policies including for:^[32]

• underwriting and reserving;
• asset-liability management;
• investment risk management;
• liquidity risk management;
• concentration risk management;
• operational risk management; and
• reinsurance and other insurance risk mitigation techniques.

3.11

Firms must develop an investment risk management policy that, where appropriate, in order to ensure effective risk management, includes internal quantitative investment limits for assets and exposures.^{[33 ]}The PRA cannot envisage circumstances where it would not be appropriate to set such internal limits and, as such, expects firms to define and operate within these limits. The PRA expects that such limits would encompass at least asset class, geographic, single-name, sector and off-balance sheet exposures that the firm would expect to hold in reasonably foreseeable market conditions.

3.12

The PRA expects quantitative investment limits to be consistent with the board’s risk appetite. As such, the PRA expects firms to document how their limits are determined and how they are consistent with the overall risk appetite and risk management of their firms. The PRA may review the appropriateness of the limits when assessing compliance with the requirements on the system of governance and investments as part of the supervisory review process.

3.13

The PRA expects that firms will review their internal quantitative investment limits in line with reviews of the firm’s investment strategy and investment risk management policy.

3.14

When setting internal quantitative investment limits for asset classes and exposures, the PRA expects firms should take into account at least the:

• nature and duration of the firm’s liabilities;
• nature and quantification of the risks associated with each category of asset and with individual assets;
• access to investment risk management capabilities proportionate to the complexity of the asset class involved (especially for any planned new categories of investment);
• need for proper diversification of assets, as set out in Investments 5.2(3);
• impact of any uncertainty on the valuation of assets, or on the ability of the firm to realise an asset’s value in the event of sale, including under stress;
• uncertainty around the timing and the channels through which investment risks may materialise and the actions available to mitigate them; and
• material reinsurance cessions and whether these create correlations of counterparty credit risk, particularly if collateral arrangements are used, whether, for example, as a result of the counterparty itself, or as a result of collateral arrangements, where utilised.

3.15

Internal quantitative investment limits should be set in order to ensure a properly diversified and resilient portfolio of assets (with an acceptable level of volatility) that avoids a material reliance on counterparties (or other common risk factors between the assets).

3.16

When setting quantitative investment limits, firms should consider an assessment of the impact of the failure of the firm’s largest counterparties.

3.17

Investments 5.2(4) requires firms to ensure that assets issued by the same issuer, or by issuers belonging to the same group, shall not expose the insurance firm to excessive risk concentration. This is an objective standard and must be assessed from the perspective of the hypothetical prudent person in the same situation.^[34]

3.18

Firms are also reminded of their obligations relating to risk concentration reporting under Article 295 of the Delegated Regulation. The PRA expects that firms will stress test their portfolios to demonstrate that they are not exposed to excessive risk concentration. The PRA expects, at the least, that the solvency of a firm would not be threatened by any plausible crystallisation of a risk related to assets issued by the same issuer or by issuers belonging to the same group.

3.19

Investments 5.2(3) requires assets to be properly diversified in such a way as to avoid excessive reliance on any particular asset, issuer or group of undertakings, or geographical area, and excessive accumulation of risk in the portfolio as a whole. This is an objective standard that must be assessed on an objective basis. One way the PRA expects that firms could demonstrate proper diversification is by stress testing their portfolios. More specifically, the PRA expects that with regard to risks arising from a particular asset, issuer or group of undertakings, or geographical area (eg default, change in government policies, deterioration in market or macroeconomic conditions), or other single source of risk:

• the solvency risk appetite of the firm is not threatened in a moderate stress scenario; and
• the solvency of the firm is not threatened in a severe stress scenario and the firm is able to recover from a severe shock and restore compliance with all its regulatory requirements.^[35]

In this context, the PRA considers that what constitutes ‘moderate’ and ‘severe’ stress scenarios depends on the individual circumstances of a firm.

4.1

When outsourcing investment-related activities, firms are subject to Chapter 7 of Conditions Governing Business, which sets out requirements for outsourcing in general. Rule 7.1 states that ‘if a firm outsources a function or any insurance or reinsurance activity, it remains fully responsible for discharging all of its obligations under the rules and other laws, regulations and administrative provisions adopted in accordance with the Solvency II Directive’.

4.2

As such, firms that wholly or partially outsource their investment function themselves remain subject to the requirements of the PPP. Firms must ensure that any external investment manager only invests their assets in accordance with the PPP. Boards must be aware of any outsourced investment activities and must monitor, regularly review and be satisfied that these align with the firm’s strategy, strategic asset allocation and risk appetite.

4.3

The PRA expects that firms will undertake appropriate due diligence in relation to outsourced investment activities. A firm’s risk function should have the ability to understand and manage the specific risks associated with outsourcing its investment function or parts of its investment function. Additionally firms should be confident that any external party has sufficient risk management expertise to comply with this SS.

4.4

Article 274 of the Solvency II EU Delegated Regulation applies for outsourced investment functions/activities. For the purposes of this article, the PRA would normally expect ‘investment’ to be regarded as a ‘critical or important operational’ function or activity. Consistent with the European Insurance and Occupational Pensions Authority (EIOPA) Guidelines 60 and 63 (System of governance), firms should identify a process to determine which functions and activities are critical or important.^[36] The PRA would expect to challenge firms to explain their reasoning if as a result of this process they determine that investment functions are not ‘critical or important’.

5.1

This chapter does not apply to firms’ investments in assets covering technical provisions (TPs) for linked long-term contracts of insurance, except where the assets are held to cover the additional TPs in respect of policyholder liabilities. This includes those for any guarantee of investment performance or other guaranteed benefit provided under those contracts. 

5.2

Investments in non-traded assets can be an appropriate match for insurance liabilities, particularly annuities or Periodic Payment Order liabilities (PPOs), but they can also give rise to additional risks. For example, they can be difficult to value in the absence of regular market pricing and to sell in a timely manner, particularly under stressed market conditions.

5.3

 In addition to the factors set out in paragraph 3.14 of this SS, the PRA also expects that, prior to investing in a non-traded asset, when determining any internal investment limit, and as part of ongoing practice, firms will also consider and assess matters including the following:

• the appropriateness and robustness of the valuation methodology under a suitable range of operating conditions;
• in the case of internally-rated assets, the robustness, capability and maturity of the internal rating framework;
• if using an internal model, the ability to justify and reconcile any material differences between how investment risk is assessed for capital purposes and when applying the standards of the PPP; and
• the materiality of any embedded optionality, how this may change over time and under stress, and how any change will affect the risk profile of the asset.

5.4

Non-traded assets will often be more complex than those traded on a regulated exchange and as a result often expose firms to additional risk. The PRA expects that for the purpose of identifying the risks arising from these investments (in line with Investments 2.1(1)), firms will take particular care to consider both the systemic and idiosyncratic risks arising from the features of each investment.

5.5

Non-traded assets are often bought and sold less frequently than traded assets or in less deep, liquid and transparent markets. Therefore, there is often relatively little credible historical pricing data that can be used to measure the risks they introduce as required under Investments 2.1(1). Firms with historical records for their own assets are unlikely to have access to historical data relating to the market as a whole. It is therefore important for firms to undertake a fundamental analysis of the underlying risks on their non-traded assets.

5.6

The PRA expects that the level of expertise of key persons (including investment managers) and the robustness of risk management systems and controls would increase commensurate with any increases in the scale, complexity or concentration of investments in non-traded assets.

5.7

The PRA reminds firms of its expectations relating to liquidity risk arising from investment in non-traded assets, as set out in SS18/19.^[37]

5.8

Conditions Governing Business 3.4 requires firms to demonstrate compliance with the Investments Part of the PRA Rulebook. For this purpose, firms investing in non-traded assets should at a minimum be able to demonstrate that:

• key persons have sufficient experience and expertise to be able to understand and manage the risks involved in the assets held and challenge decisions;
• the suitability of an investment to match the firm’s liabilities has been assessed in the light of suitably severe stress scenarios projected over suitably long horizons. The PRA would not expect an investment to be suitable if under such stress scenarios it resulted in a material deterioration in the firm’s solvency or liquidity position;
• investments in ‘assets not admitted to trading on a regulated financial market’ are kept at ‘prudent levels’ in accordance with Investments 5.2(2), on an objective basis from the standpoint of the hypothetical prudent person in similar circumstances; and
• the firm’s internal investment limits (in accordance with the guidance set out in Chapter 3 of this SS) are adequate to ensure that such investments are kept to such prudent levels.

6.1

The PRA recognises that there is inherent uncertainty in the valuation of any asset. This will be most material for any asset where there are no quoted market prices in active markets in the same assets, as it is not possible to know for certain what a buyer would pay to a seller for such an asset at a point in time. The less deep, liquid and transparent the market for a particular asset, the greater reliance a firm will have to place on modelled values, and hence the greater the valuation uncertainty.^[38]

6.2

Valuation uncertainty is therefore a key risk for non-traded assets, and is also likely to be a risk for listed assets that are thinly traded, including cases where an investor holds a material proportion of an issuance. The PRA expects that firms take into account valuation uncertainty risk for the purposes of complying with the PPP and be able to demonstrate that they comply with the risk management requirements set out in Conditions Governing Business 3.4 in relation to valuation uncertainty risk.

6.3

When assessing whether firms are appropriately managing valuation uncertainty risk, the PRA will consider (among other things) the extent to which the firm complies with its requirements under the Delegated Regulation in relation to the valuation of assets. In particular, in relation to the alternative valuation methods referred to in Article 10(3) of the Delegated Regulation, which are used to value the non-traded assets, the PRA will consider whether the firm has credibly justified the alternative valuation approach used. The PRA will also consider whether the firm has adequately assessed the valuation uncertainty of those assets in accordance with Article 263 of the Delegated Regulation. 

6.4

When assessing firms’ management of valuation uncertainty risk for the purposes of complying with the PPP, the PRA will also consider the extent to which the firm satisfies the requirements under Article 267 of the Delegated Regulation relating to the internal control of valuation of assets. The PRA expects that the more material the firm’s exposure, the greater the skills and expertise that will be required of the persons involved in the valuation of these assets.

6.5

In accordance with Conditions Governing Business 7.1, firms remain fully responsible for discharging all of their obligations under the rules and other laws, regulations and administrative provisions adopted in accordance with the Solvency II Directive when they outsource functions or any insurance or reinsurance activities. Accordingly, firms must take the steps necessary to adequately assess and manage valuation uncertainty risk, regardless of whether the valuation function is outsourced. In assessing a firm’s compliance with the requirements of the PPP in the context of its investment in non-traded assets, where the firm does outsource the valuation function, the PRA will consider (among other things) the extent to which the firm complies with the requirements for outsourcing set out in Article 274 of the Delegated Act.

6.6

The PRA expects that firms will have effective systems and controls in place to limit and manage their exposure to valuation uncertainty. This should include a framework for quantifying or grading their exposure to this risk, to enable them to define appropriate internal investment limits (in line with paragraph 2.2 of this SS) in respect of their investment in assets that expose them to valuation uncertainty. The appropriateness of that framework will depend on all the circumstances in each case, taking into account the principle of proportionality. The PRA expects that the level of valuation uncertainty and associated risks should be consistent with the defined risk appetite and investment strategy of the firm, including in stress scenarios.

6.7

When undertaking a risk assessment to determine the appropriateness of investment in assets not yet approved by the board (in line with paragraph 2.2 of this SS), the PRA also expects that firms will quantify valuation uncertainty.

6.8

The PRA notes that valuation uncertainty is distinct from uncertainty about the potential realisable value of an asset in the future. However, where the value of an asset is uncertain, this will obviously increase uncertainty about the potential realisable value of that asset. Firms should therefore take valuation uncertainty into account when stress testing their portfolios in line with the expectation set in paragraph 3.18 of this SS.

7.1

In respect of assets backing TPs, the PPP requires that these must be invested ‘in a manner appropriate to the nature and duration of the firm’s insurance and reinsurance liabilities and in the best interests of all policyholders, taking into account any disclosed policy objectives’.^[39]

7.2

The requirement for assets backing TPs to be invested in policyholders’ best interests has particular implications for certain intragroup transactions such as intragroup loans and participations or arrangements to that effect (‘intragroup transactions’). Investments in or loans to other group companies may be in the interests of shareholders but they may not necessarily be in the best interests of policyholders. For example, the issuers of loans may be less willing or able to enforce repayment, particularly where loans are upstream. The PRA expects that it would be a high hurdle for firms to demonstrate that intragroup loans and participations are in the best interests of policyholders and, as such, a high hurdle to demonstrate that they are appropriate for covering TPs.

7.3

The PPP requires that in the case of a conflict of interest, ‘the investment of assets is made in the best interest of all policyholders’.^[40] This provision applies to all asset classes but is highlighted here as the PRA considers that investment in intragroup assets is very likely to lead to a conflict of interest (for example, between shareholders and policyholders, between subsidiaries and parent companies, and between policyholders in different subsidiaries). The PRA therefore expects that a firm’s board should be satisfied that any conflicts of interest have been resolved in the best interest of policyholders before investing in an intragroup asset. Further to this, the PRA expects that any conflicts of interest that arise following investment in an intragroup transaction should also be resolved in the best interest of policyholders, which may mean ceasing to invest in that asset.

7.4

Intragroup reinsurance is used to back TPs, but the PRA generally expects that intragroup reinsurance arrangements with no element of investment are less likely to present conflicts of interest in the way it observes, for example, that intragroup loans can. Intragroup reinsurance transfers can be, and usually are, different in substance economically from intragroup investments. They usually transfer risk away from the ceding firm in a way designed to ensure that the insurance obligations are closely matched by the reinsurance. As such, in many situations, the PRA would expect the interests of policyholders and the interests of the ceding firm to be better aligned.

7.5

Nevertheless, the PRA remains very interested in intragroup reinsurance arrangements recognising that they carry risks of their own that firms need to be able to measure, monitor, manage, control and mitigate. The PRA will look to the economic substance of arrangements, and where an intragroup reinsurance arrangement is structured to effectively function as a loan the PRA would treat it as such for the purposes of this section.

7.6

As with any investment, intragroup assets are subject to all the other requirements placed on firms under the PPP. As an example of this, the PRA expects that intragroup assets are subject to at least the same level of ‘arm’s length’ scrutiny and risk management as other assets, as well as proper governance and documentation with regard to:

• conflicts of interest;
• concentration risk;
• credit risk;
• liquidity risk;
• legal and operational risk;
• wrong-way risk where counterparty default risk is positively correlated with other risks borne by the firm (when the crystallisation of a risk could affect the financial condition both of the firm and of other group entities); and
• increased complexity of the group structure leading to dependencies that increase the fragility of the group or entity in stress scenarios.

8.1

The PPP applies to all assets, including reinsurance arrangements. As for any asset, the PRA will take a case-by-case approach to considering whether reinsurance arrangements meet the PPP’s standards (as set out in Chapter 1), and will take into account a particular firm’s circumstances, including the impact of various risk mitigation factors such as the use of collateral. The PRA has set out its expectations in relation to firms’ management of risk – particularly counterparty credit risk – in relation to their reinsurance arrangements in SS20/16.